Full Version of the April 2013 Issue

Publication
Article
The Journal of Targeted Therapies in CancerApril 2013
Volume 1
Issue 6

Full Version of The International Journal of Targeted Therapies in Cancer from April 2013

View the full PDF

The International Journal of Targeted Therapies in Canceris focused on the use of targeted therapies and personalized medicine—one of the most rapidly growing and clinically challenging areas of oncology today.

This issue contains articles on:

  • PI3K Inhibitors in Breast Cancer Treatment
  • Cabozantinib in Medullary Thyroid Cancer
  • Modulating the Immune System to Treat Non-Small Cell Lung Cancer

Open publication- Freepublishing-More breast cancer

Articles in this issue
Full Version of the April 2013 Issue
Full Version of the April 2013 Issue

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Related Content
TROP-2 Inhibitors Are Explored in Breast Cancer

TROP-2 Inhibitors Are Explored in Breast Cancer

Tony Berberabe, MPH
June 28th 2025
Article

Discover the latest advancements in breast cancer treatment at the 24th Annual International Congress, featuring expert insights and groundbreaking research.

Read More

Bladder-Sparing Approaches Gaining Ground in NMIBC

Bladder-Sparing Approaches Gaining Ground in NMIBC

Tony Berberabe, MPH
June 27th 2025
Article

Innovative treatments for non–muscle-invasive bladder cancer emerge, focusing on bladder preservation and improved outcomes with novel therapies and active surveillance strategies.

Read More

Reducing Costs and Readmissions Through Data Analytics in Health Care

Reducing Costs and Readmissions Through Data Analytics in Health Care

Stephan Hawke
June 26th 2025
Article

Discover how data analytics transforms health care by reducing costs, improving patient outcomes, and enhancing operational efficiency through innovative technologies.

Read More

Earlier Use of Pembrolizumab Is Advocated in HNSCC

Earlier Use of Pembrolizumab Is Advocated in HNSCC

Robert L. Ferris, MD, PhD
June 25th 2025
Article

Perioperative pembrolizumab enhances survival rates in advanced head and neck cancer, paving the way for earlier immunotherapy integration and future treatment strategies.

Read More

Exploring the Treatment Landscape in Chronic GVHD

Exploring the Treatment Landscape in Chronic GVHD

Tony Berberabe, MPH
June 24th 2025
Article

Explore the complexities of chronic GVHD symptoms, assessment, and innovative treatment strategies, including ruxolitinib and emerging therapies.

Read More

Navigating the Treatment Landscape in Non–Clear Cell Renal Cell Carcinoma

Navigating the Treatment Landscape in Non–Clear Cell Renal Cell Carcinoma

Charles B. Nguyen, MD
June 23rd 2025
Article

Explore the complexities of non-clear cell renal cell carcinoma, its treatment challenges, and promising immunotherapy advancements for better patient outcomes.

Read More